JENNIFER CLARK: Open Payments
NPI 1245567247 · ROXBORO, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$577 in 17 payments from 9 companies in 2025. Trend: 2023 $378 · 2024 $160 · 2025 $577
Food & beverage: $577
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $268 |
| Otsuka America Pharmaceutical, Inc. | 4 | $108 |
| ABBVIE INC. | 3 | $57 |
| Exact Sciences Corporation | 2 | $35 |
| GlaxoSmithKline, LLC. | 1 | $24 |
| Phadia US Inc. | 1 | $23 |
| Corcept Therapeutics | 1 | $23 |
| Novo Nordisk Inc | 1 | $20 |
| Lilly USA, LLC | 1 | $19 |
Products named: AIRSUPRA, REXULTI, VRAYLAR, The Cologuard Plus Collection Kit, BEXSERO, ImmunoCAP, Korlym, Wegovy.
Industry payments across NC — which companies pay providers there.
